The UALCAN analysis reveals an interesting trend: TIMM9 expression levels in the mTOR Pathway-altered group consistently show greater deviation from the Normal group compared to the Others group (Fig.
← all excerpts
TIMM9 as a prognostic biomarker in multiple cancers and its associated biological processes.
1
—
—